书目名称 | Valuation in Life Sciences | 副标题 | A Practical Guide | 编辑 | Boris Bogdan,Ralph Villiger | 视频video | | 概述 | First complete guide to valuation in life sciences (pharma, biotech, medtech).Step-by-step explanation of how to practice valuation of projects and contracts.With relevant data and many real-life exam | 图书封面 |  | 描述 | Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art. In the following chapters we will provide the user with a concise val- tion manual, providing transparency and practical insight for all dealing with valuation in life sciences: project and portfolio managers, licensing executives, business developers, technology transfer managers, entrep- neurs, investors, and analysts. The purpose of the book is to explain how to apply discounted cash flow and real options valuation to life sciences p- jects, i.e. to license contracts, patents, and firms. We explain the fun- mentals and the pitfalls with case studies so that the reader is capable of performing the valuations on his own and repeat the theory in the exercises and case studies. The book is structured in five parts: In the first part, the introduction, we discuss the role of the players in the life sciences industry and their p- ticular interests. We describe why valuation | 出版日期 | Book 2010Latest edition | 关键词 | Biotech; Computerassistierte Detektion; Medtech; Pharma; Radiologieinformationssystem; Real Options; Valua | 版次 | 3 | doi | https://doi.org/10.1007/978-3-642-10820-4 | isbn_softcover | 978-3-642-42584-4 | isbn_ebook | 978-3-642-10820-4 | copyright | Springer-Verlag Berlin Heidelberg 2010 |
The information of publication is updating
|
|